First line treatment of metastatic renal cell carcinoma: Two standards with different toxicity profile

by Iacovelli, Roberto, Verzoni, Elena, De Braud, Filippo, Procopio, Giuseppe
Published 2014

Study design and clinical evidence in mRCC: Can we save axitinib as a first-line therapy?

by Iacovelli, Roberto, Verzoni, Elena, De Braud, Filippo Maria, Procopio, Giuseppe
Published 2014

Sites of disease as predictors of outcome in metastatic renal cell carcinoma patients treated with first-line sunitinib or sorafenib

by Grassi, Paolo, Verzoni, Elena, Porcu, Luca, Iacovelli, Roberto, de Braud, Filippo, Procopio, Giuseppe
Published in Ther Adv Urol (2015)

Incidence and relative risk of grade 3 and 4 diarrhoea in patients treated with capecitabine or 5- fluorouracil: a meta-analysis of published trials

by Iacovelli, Roberto, Pietrantonio, Filippo, Palazzo, Antonella, Maggi, Claudia, Ricchini, Francesca, de Braud, Filippo, Di Bartolomeo, Maria
Published in Br J Clin Pharmacol (2014)

Bevacizumab treatment in the elderly patient with metastatic colorectal cancer

by Di Bartolomeo, Maria, Maggi, Claudia, Ricchini, Francesca, Pietrantonio, Filippo, Iacovelli, Roberto, de Braud, Filippo, Inno, Alessandro
Published in Clin Interv Aging (2015)

Targeted treatments in advanced renal cell carcinoma: focus on axitinib

by Verzoni, Elena, Grassi, Paolo, Testa, Isabella, Iacovelli, Roberto, Biondani, Pamela, Garanzini, Enrico, De Braud, Filippo, Procopio, Giuseppe
Published 2014

Chemotherapy or Targeted Therapy as Second-Line Treatment of Advanced Gastric Cancer. A Systematic Review and Meta-Analysis of Published Studies

by Iacovelli, Roberto, Pietrantonio, Filippo, Farcomeni, Alessio, Maggi, Claudia, Palazzo, Antonella, Ricchini, Francesca, de Braud, Filippo, Di Bartolomeo, Maria
Published 2014

Role of MGMT as biomarker in colorectal cancer

by Inno, Alessandro, Fanetti, Giuseppe, Di Bartolomeo, Maria, Gori, Stefania, Maggi, Claudia, Cirillo, Massimo, Iacovelli, Roberto, Nichetti, Federico, Martinetti, Antonia, de Braud, Filippo, Bossi, Ilaria, Pietrantonio, Filippo
Published in World J Clin Cases (2014)

Gain of ALK Gene Copy Number May Predict Lack of Benefit from Anti-EGFR Treatment in Patients with Advanced Colorectal Cancer and RAS-RAF-PI3KCA Wild-Type Status

by Pietrantonio, Filippo, Maggi, Claudia, Di Bartolomeo, Maria, Facciorusso, Maria Grazia, Perrone, Federica, Testi, Adele, Iacovelli, Roberto, Miceli, Rosalba, Bossi, Ilaria, Leone, Giorgia, Milione, Massimo, Pelosi, Giuseppe, de Braud, Filippo
Published 2014

DPD and UGT1A1 deficiency in colorectal cancer patients receiving triplet chemotherapy with fluoropyrimidines, oxaliplatin and irinotecan

by Falvella, Felicia Stefania, Cheli, Stefania, Martinetti, Antonia, Mazzali, Cristina, Iacovelli, Roberto, Maggi, Claudia, Gariboldi, Manuela, Pierotti, Marco Alessandro, Di Bartolomeo, Maria, Sottotetti, Elisa, Mennitto, Roberta, Bossi, Ilaria, de Braud, Filippo, Clementi, Emilio, Pietrantonio, Filippo
Published in Br J Clin Pharmacol (2015)

FOLFOX-4 Chemotherapy for Patients With Unresectable or Relapsed Peritoneal Pseudomyxoma

by Pietrantonio, Filippo, Maggi, Claudia, Fanetti, Giuseppe, Iacovelli, Roberto, Di Bartolomeo, Maria, Ricchini, Francesca, Deraco, Marcello, Perrone, Federica, Baratti, Dario, Kusamura, Shigeki, Tamborini, Elena, Castano, Alessandra, Consonni, Paola Valentina, Bossi, Ilaria, Gavazzi, Cecilia, Milione, Massimo, Pelosi, Giuseppe, de Braud, Filippo
Published 2014